1.A Case of Leiomyoma of the Auricle.
Kyu Ho LEE ; Sung Phil JO ; Sun Ok KIM ; Jun Hee BYEON
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2003;30(3):342-344
Leiomyoma is benign neoplasm of smooth muscle origin, which generally originate in gastrointestinal and female genital tract. Within head and neck, the common sites are the cervical esophagus and/or oral cavity. Their occurrence in the ear is extremely rare. There have been reported less than ten cases of leiomyomas of auricle in the world and can not be found in the Korean literature. Leiomyoma arising from auricle is classifed into two types, one from the erector pilar muscle and the other from the muscular coats of blood vessel. We present a case of leiomyoma in scapha of the ear. This benign tumor was treated by complete excision. This tumor was small, round, firm, solitary and microscopically well-encapsulated. The clinical and pathologic findings of auricular leiomyoma were described.
Blood Vessels
;
Ear
;
Esophagus
;
Female
;
Head
;
Humans
;
Leiomyoma*
;
Mouth
;
Muscle, Smooth
;
Neck
2.Long-term Survival following Surgical Resection for Recurrence of Pulmonary Pleomorphic Carcinoma.
Jin Gu LEE ; Kyung Young CHUNG ; In Kyu PARK ; Dae Joon KIM ; Cheon Sung BYEON ; Sang Ho CHO
The Korean Journal of Thoracic and Cardiovascular Surgery 2007;40(8):587-589
Pulmonary pleomorphic carcinomas are rare malignant tumors that account for 0.1 to 0.4% of all lung cancers. They are notable for their aggressive clinical behavior and poor prognosis. We report here on a patient who is alive and disease-free 12 years after receiving surgical treatment for the rib recurrence of pulmonary pleomorphic carcinoma.
Humans
;
Lung Neoplasms
;
Prognosis
;
Recurrence*
;
Ribs
3.A Case of Duodenal Relapse of Epstein-Barr Virus-positive, CD56-negative Extranodal NK/T-cell Lymphoma, Nasal Type.
Kyu Jong KIM ; Gin Hyug LEE ; Seong Soo HONG ; Jeong Sik BYEON ; Suk Kyun YANG ; Jin Ho KIM ; Young Il MIN ; Joo Ryung HUH
Korean Journal of Gastrointestinal Endoscopy 2005;30(4):204-209
Mature T-cell and natural killer-cell neoplasms account for 10 to 15% of all non-Hodgkin's lymphomas. Of the various subtypes of mature T-cell and NK-cell lymphomas, extranodal NK/T-cell lymphoma, nasal type (nasal type NK/T-L) is relatively more common among Asians including Koreans. Nasal type NK/T-L is an aggressive, Epstein-Barr virus-associated lymphoma with characteristic expression of NK-cell antigen CD56. In this report, we present an unusual case of EBV(+), CD56(-) NK/T-L of oropharynx which recurred in duodenum after the period of complete remission lasting for 10 years. A 58-year-old woman presented with 3 months history of abdominal pain. Gastroduodenoscopy showed the diffuse wall thickening with multiple ulcerations in bulb and proximal second portion of the duodenum. Pathological examination revealed the infiltration of atypical lymphocytes, which was positive for CD3, CD4, CD5, TIA-1, and EBV and was negative for CD15, CD20, and CD56, consistent with NK/T-L of mature T-cell origin. The past medical history included the presence of oropharyngeal mass 10 years earlier, which was diagnosed as polymorphic reticulosis. The mass resolved completely after the radiation therapy, and she remained free of the disease for 10 years. Upon review, the oropharyngeal biopsy showed an identical morphology and immunophenotype with duodenal lesion. In conclusion, we experienced an unusal case of NK/T-cell lymphoma, nasal type recured in the duodenum.
Abdominal Pain
;
Asian Continental Ancestry Group
;
Biopsy
;
Duodenum
;
Female
;
Granuloma, Lethal Midline
;
Herpesvirus 4, Human
;
Humans
;
Lymphocytes
;
Lymphoma*
;
Lymphoma, Non-Hodgkin
;
Middle Aged
;
Oropharynx
;
Recurrence*
;
T-Lymphocytes
;
Ulcer
4.Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients.
Yun Hwa JUNG ; Won Jik LEE ; Jae Ho BYEON ; In Kyu LEE ; Chi Wha HAN ; In Sook WOO
The Korean Journal of Internal Medicine 2017;32(5):926-929
No abstract available.
Administration, Metronomic
;
Aged*
;
Capecitabine*
;
Colorectal Neoplasms*
;
Drug Therapy*
;
Humans
5.Degenerative Changes of Spine in Helicopter Pilots.
Joo Hyeon BYEON ; Jung Won KIM ; Ho Joong JEONG ; Young Joo SIM ; Dong Kyu KIM ; Jong Kyoung CHOI ; Hyoung June IM ; Ghi Chan KIM
Annals of Rehabilitation Medicine 2013;37(5):706-712
OBJECTIVE: To determine the relationship between whole body vibration (WBV) induced helicopter flights and degenerative changes of the cervical and lumbar spine. METHODS: We examined 186 helicopter pilots who were exposed to WBV and 94 military clerical workers at a military hospital. Questionnaires and interviews were completed for 164 of the 186 pilots (response rate, 88.2%) and 88 of the 94 clerical workers (response rate, 93.6%). Radiographic examinations of the cervical and the lumbar spines were performed after obtaining informed consent in both groups. Degenerative changes of the cervical and lumbar spines were determined using four radiographs per subject, and diagnosed by two independent, blinded radiologists. RESULTS: There was no significant difference in general and work-related characteristics except for flight hours and frequency between helicopter pilots and clerical workers. Degenerative changes in the cervical spine were significantly more prevalent in the helicopter pilots compared with control group. In the cervical spine multivariate model, accumulated flight hours (per 100 hours) was associated with degenerative changes. And in the lumbar spine multivariate model, accumulated flight hours (per 100 hours) and age were associated with degenerative changes. CONCLUSION: Accumulated flight hours were associated with degenerative changes of the cervical and lumbar spines in helicopter pilots.
Aircraft*
;
Hospitals, Military
;
Humans
;
Informed Consent
;
Military Personnel
;
Spine*
;
Vibration
;
Surveys and Questionnaires
6.A clinicopathologic study on ameloblastoma
Iel Yong SUNG ; Sung Ho RYU ; Sang Hoon SHIN ; Uk Kyu KIM ; Jong Ryoul KIM ; In Kyo CHUNG ; Ki Jeong BYEON
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2003;25(1):41-48
Ameloblastoma
;
Bicuspid
;
Busan
;
Female
;
Humans
;
Male
;
Mandible
;
Molar
;
Odontogenic Cysts
;
Odontogenic Tumors
;
Recurrence
;
Retrospective Studies
;
Surgery, Oral
;
Tooth
;
Tooth, Impacted
7.Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer
Jinyoung BYEON ; Eunhye KANG ; Ji-Jung JUNG ; Jong-Ho CHEUN ; Kwan Sik SEO ; Hong-Kyu KIM ; Han-Byoel LEE ; Wonshik HAN ; Hyeong-Gon MOON
Journal of Breast Cancer 2024;27(5):323-333
Purpose:
Although numerous studies have identified potential risk factors for ipsilateral lymphedema development in patients with breast cancer following axillary node dissection, the risk factors for lymphedema in patients undergoing sentinel node biopsy without axillary dissection remain unclear. In this study, we aimed to determine the real-world incidence and risk factors for lymphedema in such patients.
Methods:
We conducted a single-center, retrospective review of medical records of patients with breast cancer who underwent sentinel node biopsy alone. The development cohort (5,051 patients, January 2017–December 2020) was analyzed to identify predictors of lymphedema, and a predictive model was subsequently created. A validation cohort (1,627 patients, January 2014–December 2016) was used to validate the model.
Results:
In the development cohort, 49 patients (0.9%) developed lymphedema over a median follow-up of 56 months, with most cases occurring within the first three years post-operation.Multivariate analysis revealed that a body mass index (BMI) of 30 kg/m2 or above, radiation therapy (RTx), chemotherapy, and more than three harvested lymph nodes significantly predicted lymphedema. The predictive model showed an area under the curve of 0.824 for systemic chemotherapy, with the number of harvested lymph nodes being the most significant factor. Patients were stratified into four risk groups, showing lymphedema incidences of 3.3% in the highest-risk group and 0.1% in the lowest-risk group. In the validation cohort, the incidences were 1.7% and 0.2% for the highest and lowest risk groups, respectively.
Conclusion
The lymphedema prediction model identifies RTx, chemotherapy, BMI ≥ 30 kg/m2 , and more than three harvested lymph nodes as significant risk factors. Although the overall incidence is low, the risk is notably influenced by the extent of lymph node removal and systemic therapies. The model’s high negative predictive value supports its application in designing tailored lymphedema surveillance programs for early intervention.
9.Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer
Jinyoung BYEON ; Eunhye KANG ; Ji-Jung JUNG ; Jong-Ho CHEUN ; Kwan Sik SEO ; Hong-Kyu KIM ; Han-Byoel LEE ; Wonshik HAN ; Hyeong-Gon MOON
Journal of Breast Cancer 2024;27(5):323-333
Purpose:
Although numerous studies have identified potential risk factors for ipsilateral lymphedema development in patients with breast cancer following axillary node dissection, the risk factors for lymphedema in patients undergoing sentinel node biopsy without axillary dissection remain unclear. In this study, we aimed to determine the real-world incidence and risk factors for lymphedema in such patients.
Methods:
We conducted a single-center, retrospective review of medical records of patients with breast cancer who underwent sentinel node biopsy alone. The development cohort (5,051 patients, January 2017–December 2020) was analyzed to identify predictors of lymphedema, and a predictive model was subsequently created. A validation cohort (1,627 patients, January 2014–December 2016) was used to validate the model.
Results:
In the development cohort, 49 patients (0.9%) developed lymphedema over a median follow-up of 56 months, with most cases occurring within the first three years post-operation.Multivariate analysis revealed that a body mass index (BMI) of 30 kg/m2 or above, radiation therapy (RTx), chemotherapy, and more than three harvested lymph nodes significantly predicted lymphedema. The predictive model showed an area under the curve of 0.824 for systemic chemotherapy, with the number of harvested lymph nodes being the most significant factor. Patients were stratified into four risk groups, showing lymphedema incidences of 3.3% in the highest-risk group and 0.1% in the lowest-risk group. In the validation cohort, the incidences were 1.7% and 0.2% for the highest and lowest risk groups, respectively.
Conclusion
The lymphedema prediction model identifies RTx, chemotherapy, BMI ≥ 30 kg/m2 , and more than three harvested lymph nodes as significant risk factors. Although the overall incidence is low, the risk is notably influenced by the extent of lymph node removal and systemic therapies. The model’s high negative predictive value supports its application in designing tailored lymphedema surveillance programs for early intervention.